Sepsis and AKI in ICU patients: The Role of plasma biomarkers

Critical Care Research and Practice

Volumn 2012, Issue , 2012, Pages

  Lentini, Paolo ^a,b   De Cal, Massimo ^b,c   Clementi, Anna ^c   D'Angelo, Angela ^b   Ronco, Claudio ^c  

^a San Bassiano Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866253109     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2012/856401     Document Type: Article

References (24)

1. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J. L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B (Pubitemid 36444440)
2. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 101 6 1644 1655 2-s2.0-77649201783
3. Martin G. S., Mannino D. M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine 2003 348 16 1546 1554 2-s2.0-0037451929 10.1056/NEJMoa022139 (Pubitemid 36437931)
4. Brun-Buisson C., The epidemiology of the systemic inflammatory response. Intensive Care Medicine 2000 26 1 S64 S74 2-s2.0-0034108825 (Pubitemid 30184495)
5. Paterson R. L., Webster N. R., Sepsis and the systemic inflammatory response syndrome. Journal of the Royal College of Surgeons of Edinburgh 2000 45 3 178 182 2-s2.0-0034085626 (Pubitemid 30394383)
6. Brade H., Brade L., Schade U., Zähringer U., Holst O., Kuhn H. M., Rozalski A., Röhrscheidt E., Rietschel E. T., Structure, endotoxicity, immunogenicity and antigenicity of bacterial lipopolysaccharides (endotoxins, O-antigens). Progress in Clinical and Biological Research 1988 272 17 45 2-s2.0-0023799778
7. Pfeiffer R., Untersuchungen über das Choleragift. Zeitschrift für Hygiene und Infektionskrankheiten 1892 11 1 393 412 2-s2.0-0001100915 10.1007/BF02284303
8. Cruz D. N., Bellomo R., Ronco C., Clinical effects of polymyxin B-immobilized fiber column in septic patients. Contributions to Nephrology 2007 156 444 451 2-s2.0-34247566234 10.1159/0000102138
9. Das U. N., Critical advances in septicemia and septic shock. Critical Care 2000 4 5 290 296 2-s2.0-0033797854 10.1186/cc711
10. Bagshaw S. M., Uchino S., Bellomo R., Morimatsu H., Morgera S., Schetz M., Tan I., Bouman C., Macedo E., Gibney N., Tolwani A., Oudemans-van Straaten H. M., Ronco C., Kellum J. A., Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clinical Journal of the American Society of Nephrology 2007 2 3 431 439 2-s2.0-34548229961 10.2215/CJN.03681106
11. Hoste E. A. J., Lameire N. H., Vanholder R. C., Benoit D. D., Decruyenaere J. M. A., Colardyn F. A., Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. Journal of the American Society of Nephrology 2003 14 4 1022 1030 2-s2.0-0037378947 10.1097/01.ASN.0000059863.48590.E9 (Pubitemid 36359284)
12. Lopes J. A., Jorge S., Resina C., Santos C., Neves J., Antunes F., Prata M. M., Acute renal failure in patients with sepsis. Critical Care 2007 11, article no. 411 2-s2.0-39549084929 10.1186/cc5735 (Pubitemid 46736801)
13. Marshall J. C., Walker P. M., Foster D. M., Harris D., Ribeiro M., Paice J., Romaschin A. D., Derzko A. N., Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Critical Care 2002 6 4 342 348 2-s2.0-0036333006 10.1186/cc1522 (Pubitemid 34863703)
14. Monti G., Bottiroli M., Pizzilli G., Minnini M., Terzi V., Vecchi I., Gesu G., Brioschi P., Vesconi S., Casella G., Endotoxin activity level and septic shock: a possible role for specific anti-endotoxin therapy? Contributions to Nephrology 2010 167 102 110 2-s2.0-77954569611 10.1159/000315924
15. Charpentier J., Luyt C. E., Fulla Y., Vinsonneau C., Cariou A., Grabar S., Dhainaut J. F., Mira J. P., Chiche J. D., Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Critical Care Medicine 2004 32 3 660 665 2-s2.0-1542614334 10.1097/01.CCM.0000114827. 93410.D8 (Pubitemid 38340060)
16. Bagshaw S. M., George C., Bellomo R., Early acute kidney injury and sepsis: a multicentre evaluation. Critical Care 2008 12 2, article no. R47 2-s2.0-42449083303 10.1186/cc6863 (Pubitemid 351567061)
17. Ronco C., cronco@goldnet.it Haapio M., House A. A., Anavekar N., Bellomo R., Cardiorenal syndrome. Journal of the American College of Cardiology 2008 52 19 1527 1539 10.1016/j.jacc.2008.07.051
18. Maisel A., Mueller C., State of the art: using natriuretic peptide levels in clinical practice. European Journal of Heart Failure 2008 10 9 824 839 2-s2.0-51549120537 10.1016/j.ejheart.2008.07.014
19. Bruch C., Fischer C., Sindermann J., Stypmann J., Breithardt G., Gradaus R., Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. American Journal of Cardiology 2008 102 4 469 474 2-s2.0-50949110613 10.1016/j.amjcard.2008.03.082
20. Thurman J. M., Parikh C. R., Peeking into the black box: new biomarkers for acute kidney injury. Kidney International 2008 73 4 379 381 2-s2.0-38749134500 10.1038/sj.ki.5002739 (Pubitemid 351186297)
21. Vaidya V. S., Ferguson M. A., Bonventre J. V., Biomarkers of acute kidney injury. Annual Review of Pharmacology and Toxicology 2008 48 463 493 2-s2.0-41149106514 10.1146/annurev.pharmtox.48.113006.094615 (Pubitemid 351738161)
22. Damman K., van Veldhuisen D. J., Navis G., Voors A. A., Hillege H. L., Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. European Journal of Heart Failure 2008 10 10 997 1000 2-s2.0-53249124631 10.1016/j.ejheart.2008.07. 001
23. Poniatowski B., Malyszko J., Bachorzewska-Gajewska H., Malyszko J. S., Dobrzycki S., Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney and Blood Pressure Research 2009 32 2 77 80 2-s2.0-61849137722 10.1159/000208989
24. Lentini P., de Cal M., Cruz D., Chronopoulos A., Soni S., Nalesso F., Zanella M., Garzotto F., Brendolan A., Piccinni P., Ronco C., The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. Journal of Critical Care 2010 25 4 605 609 2-s2.0-78049486554 10.1016/j.jcrc.2010.04.006